Apex Capital Management’s Eli Lilly LLY Stock Holding History

Apex Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.68M	Sell	64,984 -6,965	-10%	-$527K	0.1%	152
2015 Q4	$6.06M	Sell	71,949 -1,416	-2%	-$118K	0.14%	140
2015 Q3	$6.14M	Buy	73,365 +3,031	+4%	+$256K	0.14%	130
2015 Q2	$5.87M	Sell	70,334 -741	-1%	-$56.5K	0.13%	137
2015 Q1	$5.16M	Sell	71,075 -5,689	-7%	-$405K	0.12%	143
2014 Q4	$5.3M	Sell	76,764 -686	-0.9%	-$46.3K	0.14%	131
2014 Q3	$5.02M	Buy	77,450 +1,370	+2%	+$86.7K	0.15%	112
2014 Q2	$4.73M	Sell	76,080 -1,869	-2%	-$112K	0.15%	112
2014 Q1	$4.59M	Buy	77,949 +101	+0.1%	+$5.64K	0.16%	107
2013 Q4	$3.97M	Sell	77,848 -6,852	-8%	-$343K	0.15%	111
2013 Q3	$4.26M	Sell	84,700 -52,859	-38%	-$2.77M	0.19%	95
2013 Q2	$6.76M	Buy	+137,559	New	+$7.48M	0.33%	85

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Apex Capital Management's LLY Position: Q1 2016 in Review

Apex Capital Management reduced its Eli Lilly (LLY) stake by 9.7% in Q1 2016, selling an estimated $527K and leaving 64,984 shares worth $4.68M. The position accounts for 0.1% of the portfolio, ranked #152.

Apex Capital Management first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.76M in Q2 2013. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

Apex Capital Management held 64,984 shares of Eli Lilly worth $4.68M as of Q1 2016.
Apex Capital Management sold 6,965 Eli Lilly shares in Q1 2016, an estimated $527K.
Eli Lilly made up 0.1% of Apex Capital Management's portfolio in Q1 2016, its #152 holding.
Apex Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
Apex Capital Management's Eli Lilly position peaked at $6.76M in Q2 2013.
1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.